德生丹治疗排卵障碍性不孕症肾虚肝郁证患者临床研究

门波; 付晓君; 宋艳丽; 张华

德生丹治疗排卵障碍性不孕症肾虚肝郁证患者临床研究

河南省中医院生殖与男科诊疗中心，河南郑州 450002

计量
- 文章访问数: 564
- HTML全文浏览量: 2
- PDF下载量: 429
- 被引次数: 0
出版历程
- 刊出日期: 2019-05-10

Clinical Research on the Desheng Elixir Treating Sterility of Ovulation Disturbance Patients with Kidney Deficiency and Liver Depression Syndrome

摘要

摘要: 目的观察中原门氏验方德生丹对排卵障碍性不孕症肾虚肝郁证患者的临床疗效。方法将120例排卵障碍性不孕症肾虚肝郁证患者随机分为中药组（采用中药德生丹）、联合组（采用中药德生丹+克罗米芬）、西药组（单纯使用克罗米芬）。治疗12周后观察3组患者优势卵泡直径、子宫内膜厚度、宫颈黏液（Insler）评分及排卵率、妊娠率及血清雌二醇（E₂）、孕酮（P）水平的变化等。结果治疗后3组优势卵泡直径与治疗前比较均显著增长（P<0.05~0.01），联合组与西药组优于中药组（P<0.01）；3组中医证候积分均显著下降（P<0.01），联合组与中药组优于西药组（P<0.01）；中药组、联合组子宫内膜厚度、Insle评分均有所增加（P<0.01），优于西药组（P<0.05~0.01）；排卵日3组血清E₂水平均有所增长（P<0.01），联合组与中药组优于西药组（P<0.05）；中药组、联合组黄体期血清P水平增长明显（P<0.01），优于西药组（P<0.05~0.01）；3组排卵率比较，联合组与西药组均优于纯中药组（P<0.05~0.01）；3组妊娠率比较，联合组优于中药组、西药组（P<0.05~0.01），中药组优于西药组（P<0.05）。结论德生丹能改善排卵障碍性不孕症肾虚肝郁证患者临床症状，减少单纯克罗米芬抑制子宫内膜的不良作用，提高临床排卵及妊娠率。
- 德生丹 /
- 排卵障碍性不孕 /
- 肾虚肝郁证 /
- 克罗米芬
Abstract: OBJECTIVE To observe the clinical effect of Zhongyuan Men's proved recipe Desheng elixir on sterility of ovulation disturbance patients with kidney deficiency and liver stagnation syndrome. METHODS 120 cases of sterility of ovulation disturbance with kidney deficiency and liver depression syndrome were randomly divided into three groups: traditional Chinese medicine group (using Desheng elixir)， combination group (using Desheng elixir + clomiphene)， western medicine group (using clomiphene only). After 12 weeks of treatment， the leading follicle diameter， endometrial thickness， cervical mucus (Insler) score， ovulation rate， pregnancy rate， serum estradiol (E₂) and progesterone (P) levels in the three groups were observed. RESULTS After treatment， the leading follicle diameter in the three groups increased significantly compared with that before treatment (P<0.05，P<0.01)， among which the combination group and the western medicine group increased more significantly (P<0.01). The TCM syndrome scores of the three groups decreased significantly (P<0.01)， among which the combination group and the Chinese medicine group decreased more significantly (P<0.01). The endometrial thickness and Insle score in the Chinese medicine group and the combination group increased (P<0.01)， more significantly than those in the western medicine group (P<0.05，P<0.01). Serum E₂ level increased in the three groups on the day of ovulation (P<0.01)， among which the combination group and the Chinese medicine group increased more significantly (P<0.05).Serum P level in the luteal phase increased significantly in the Chinese medicine group and the combination group (P<0.01)， better than that in the western medicine group (P<0.05，P<0.01). From the perspective of ovulatory rate， the combination group and the western medicine group increased more than that in the Chinese medicine group (P<0.05，P<0.01). As to the pregnancy rate， the combination group was higher than the other two (P<0.05， P<0.01) and the Chinese medicine group was higher than the western medicine group (P<0.05). CONCLUSION Desheng elixir can improve the clinical symptoms of sterility of ovulation disturbance patients with kidney deficiency and liver depression syndrome， reduce the adverse effect of clomiphene alone on inhibiting endometrium， and improve the clinical ovulation and pregnancy rate.
- Desheng elixir /
- sterility of ovulation disturbance /
- kidney deficiency and liver depression syndrome /
- clomiphene

HTML全文

参考文献(14)

[1]	谢幸，苟文丽.妇产科学[M].8版.北京:人民卫生出版社，2013:424.
[2]	张丽珠.临床生殖内分泌与不育症[M].北京:科学出版社，2001:274-278.
[3]	中药新药临床研究指导原则[M].北京:中国医药科技出版社，2002:249-253.
[4]	张玉珍.中医妇科学[M].北京:中国中医药出版社，2013:324-331.
[5]	周之平.慎斋遗书[M].北京：中国中医药出版社，2016：77-78.
[6]	刘思南，张晓甦.促排卵药物的中西医临床研究进展[J].现代中西医结合杂志，2017，26(2):215-217.
[7]	方艳，张霜.来曲唑促排治疗排卵障碍性不孕症患者的临床疗效观察[J].实用妇科内分泌杂志，2018，5(7):52-53.
[8]	娄丽霞，卫爱武.门成福教授应用四物汤加减治疗月经病经验[J].河南中医， 2010， 30(3):237-238.
[9]	蒋巧燕，卓彩琴，陈姗姗.疏肝补肾和血法治疗排卵障碍性不孕临床观察[J].光明中医，2013，28(11):2311-2312.
[10]	杨绘坤.补肾疏肝法治疗黄体功能不全致不孕不育的78例效果观察[J/OL].世界最新医学信息文摘，2015，15(97):153-157.
[11]	冯敬华，谈勇，邹亦洁，等.补肾活血中药在克罗米芬促排卵周期中对子宫内膜容受性及妊娠结局的影响[J].中国妇幼保健，2012，27(33):5331-5334.
[12]	TERAMOTO S，KATO O.Minimal ovarian stimulation with clomiphene citrate:a large scale retrospective study[J/OL].Reproad Biomed Online，2006，15(2):134-148.
[13]	HAVE IB，BLUESHTEIN M，HERMAN HG，et al.Gonadotropin-releasing hormone an-alogueas sole luteal support in antagonist-based assisted reproductive technologycycles[J].Fertil Steril，2017，107(1):130-135.
[14]	张励.中西医结合治疗排卵障碍性不孕临床观察[J].实用中医药杂志，2018，34(2):229-230.